在心脏手术前临床脆弱度量评估
Michael Pienta1, Chang He2, Melissa J Clark2
1Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.
The Annals of thoracic surgery
|November 12, 2025
概括
临床脆弱度量 (CFS) 标识了面临死亡和发病风险较高的脆弱患者. 将CFS纳入外科风险模型可能会改善患者的预测结果.
科学领域:
- 老年医学 老年医学
- 手术风险评估手术风险评估
- 健康 结果 研究 研究 结果
背景情况:
- 临床虚弱度量表 (CFS) 是一个9分级,用于通过临床面试来评估患者的虚弱度.
- 它的范围从非常健康 (1) 到绝症 (9).
研究的目的:
- 评估CFS得分与术后结果之间的关联.
- 评估CFS在现有的脆弱度量和风险模型中的实用性.
- 为了确定CFS是否改善了手术前风险分层.
主要方法:
- 在2024年1月至9月期间接受手术的3790名CFS患者中收集了CFS分数.
- 患有CFS得分≥5的患者被归类为脆弱.
- 分析了与术后结果,虚弱度指标和胸部外科医生协会 (STS) 风险模型的关联.
主要成果:
- 10.8%的患者被确定为虚弱 (CFS ≥5).
- 虚弱的患者有更高的手术死亡率 (4.84%对1.79%) 和主要发病率 (17.1%对9.5%).
- 将CFS添加到STS预测死亡风险模型中,提高了其预测准确度 (C统计从0.789增加到0.793).
结论:
- CFS是一个实用的,基于诊所的工具,不需要专门的设备.
- 慢性疲劳症评估可以提高手术前风险咨询和患者分层.
- 将CFS纳入风险模型可能会导致更好的手术决策和患者护理.
相关概念视频
Heart Failure VII: Nursing Interventions
404
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
404
Cardiomyopathy VII: Pre and Post Operative Nursing Management
268
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
268
Heart Failure IV: Classification and Diagnostic Evaluation
305
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
305
Assessment of the Cardiovascular System II: Inspection
780
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
780
Assessment of the Cardiovascular System I: Subjective Data
742
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
742
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180


